genomics

  • Read more: Assessing genetic relationships between academia and industry

    Assessing genetic relationships between academia and industry

    By Kayte Spector-Bagdady With recent reports of Google’s data deals with Ascension health and the University of Chicago, there has been a lot of attention paid recently to the sharing and use of health data by unexpected entities. But we know that patients are uncomfortable when hospitals “commercialize” or sell their health data or biospecimens…

    Image of binary and dna
  • Read more: DNA databases, cracking crimes, and confidentiality

    DNA databases, cracking crimes, and confidentiality

    By Leslie E. Wolf, JD, MPH and Laura M. Beskow, MPH, PhD In our article, Genomic databases, subpoenas, and Certificates of Confidentiality, published in Genetics in Medicine, the official journal of the American College of Medical Genetics and Genomics (ACMG), we considered the protections available to research genomic databases in light of law enforcement’s use…

    close up of DNA fingerprints
  • Read more: Time to Ban Heritable Genome Editing

    Time to Ban Heritable Genome Editing

    By Jeffrey R. Botkin We are at a critical crossroad in reproductive medicine.  How should science and society more broadly manage the powerful new technologies that can alter the genes of human embryos?  In a recent paper published in Genetics in Medicine, the official journal of the American College of Medical Genetics and Genomics (ACMG),…

    Scientist analyzes DNA gel used in genetics, forensics, drug discovery, biology and medicine
  • Read more: Considering stakeholders in policy around secondary findings in genomics

    Considering stakeholders in policy around secondary findings in genomics

    By Michael Mackley It took nearly thirteen years and an army of scientists to generate the first sequence of the human genome. Now, patients around the world are having their genomes sequenced every day. Since the first sequence was unveiled in 2003, the cost of whole-genome sequencing (WGS) has dropped from almost $1 billion to less…